Gilead Sciences, Inc. (GILD)
119.92
+0.56
(+0.47%)
USD |
NASDAQ |
Dec 10, 12:37
Gilead Sciences Market Cap: 148.78B for Dec. 10, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amgen, Inc. | 170.14B |
| Johnson & Johnson | 491.45B |
| Eli Lilly & Co. | 886.72B |
| Merck & Co., Inc. | 241.60B |
| Pfizer Inc. | 144.90B |
Market Cap Related Metrics
| PE Ratio | 18.57 |
| PS Ratio | 5.187 |
| PEG Ratio | 0.0026 |
| Price to Book Value | 6.907 |
| Price to Free Cash Flow | 16.45 |
| Price | 119.92 |
| Earnings Yield | 5.38% |
| PEGY Ratio | 0.0026 |
| Operating PE Ratio | 13.29 |
| Normalized PE Ratio | 17.35 |